Phibro Animal Health Corp (PAHC) 33.44 $PAHC
Healthcare ratings roundup
Seeking Alpha - at Seeking Alpha - Tue Apr 21, 8:42AM CDT
IPXL: 49.58 (-0.40), ROSG: 3.83 (-0.20), BCRX: 10.62 (-0.09), ALGN: 55.94 (-0.21), PAHC: 33.44 (+1.09), BMY: 66.60 (-0.21)
Medtronic, IBM Health Unit Tie Up for Diabetes Management - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 14, 1:40PM CDT
The collaboration with IBM marks yet another milestone for Medtronic (MDT), taking it closer to its aim of transforming diabetes care worldwide.
SRDX: 26.57 (+0.02), MDT: 78.01 (+0.93), PAHC: 33.44 (+1.09), IBM: 165.36 (+1.10), LMAT: 8.44 (-0.10)
NuVasive Poised on Balanced Growth, International Expansion - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 14, 1:30PM CDT
On Apr 13, 2015, we initiated our coverage on NuVasive, Inc. (NUVA).
SRDX: 26.57 (+0.02), PAHC: 33.44 (+1.09), LMAT: 8.44 (-0.10), NUVA: 43.38 (+0.10)
Zimmer (ZMH) Extends Biomet Deal Outside Date to Jul 23 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 14, 1:20PM CDT
Zimmer Holdings Inc. (ZMH) has announced an extension of the "outside date" for completing the proposed Biomet merger.
ZMH: 117.49 (+0.12), SRDX: 26.57 (+0.02), PAHC: 33.44 (+1.09), LMAT: 8.44 (-0.10)
The Growing Business Of Animal Healthcare
Value Line - Seeking Alpha - Tue Apr 14, 7:44AM CDT
By George M. Lee Despite an uneven economic recovery, demand for higher-quality animal healthcare continues to increase. Veterinary spending on pets has grown at a steady clip in recent years and ought to remain strong. Meanwhile many farmers...
VRX: 206.93 (-3.92), PAHC: 33.44 (+1.09), PFE: 34.93 (+0.04), WMT: 78.43 (+0.40), PDCO: 47.34 (+0.13), PETX: 16.15 (+0.01), LLY: 72.30 (+0.09), KIN: 7.45 (+0.25), ZTS: 47.03 (-0.51), ABC: 113.81 (-0.08), MWIV: 190.00 (+0.10), ABAX: 63.25 (-0.09), MRK: 57.69 (+0.03), ICCC: 6.32 (+0.19), TGT: 81.34 (+0.09), IDXX: 155.97 (+0.75), WOOF: 55.13 (-0.18), HSIC: 141.11 (+1.14), NVS: 103.45 (-0.62), PETM: 82.98 (+0.03)
Phibro Animal Health Corporation to Participate in Bank of America Merrill Lynch 2015 Health Care Conference
GlobeNewswire - Mon Apr 06, 12:00PM CDT
Phibro Animal Health Corporation (Nasdaq
AHC) Chairman, President and Chief Executive Officer Jack Bendheim and Chief Financial Officer Richard Johnson will address financial analysts and investors at the Bank of America Merrill Lynch 2015 Health Care Conference.
PAHC: 33.44 (+1.09)
Phibro Animal Health Corporation to Host Webcast and Conference Call on March 2015 Quarterly Financial Results
GlobeNewswire - Mon Apr 06, 12:00PM CDT
Phibro Animal Health Corporation (NasdaqAHC) will host a webcast and conference call to review third quarter financial results. A news release containing quarterly results is expected to be issued after the market closes on Monday, May 11, 2015.
PAHC: 33.44 (+1.09)
NYSE Notice for Hanger for Non Compliance with 10-K Norms - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 24, 3:10PM CDT
Hanger Inc. (HGR) recently received a notice from the New York Stock Exchange (NYSE) stating that the company is not complying with the NYSE's continued listing requirements under the timely filing criteria outlined in Section 802.01E of the NYSE Listed Company Manual.
SRDX: 26.57 (+0.02), PAHC: 33.44 (+1.09), LMAT: 8.44 (-0.10), HGR: 24.27 (+0.36)
Abaxis' (ABAX) Decision to Divest AVRL: A Strategic Fit? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 24, 1:00PM CDT
Abaxis, Inc. (ABAX), recently agreed to sell off its AVRL (Abaxis Veterinary Reference Laboratory) business to renowned animal healthcare company VCA Inc. (WOOF).
PAHC: 33.44 (+1.09), ABAX: 63.25 (-0.09), LMAT: 8.44 (-0.10), WOOF: 55.13 (-0.18)
LeMaitre Vascular a Strong Buy on Impressive Q4 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 23, 5:34PM CDT
On Mar 19, 2015, Zacks Investment Research raised LeMaitre Vascular Inc. (LMAT) to a Zacks Rank #1 (Strong Buy).
PAHC: 33.44 (+1.09), ABAX: 63.25 (-0.09), LMAT: 8.44 (-0.10), INGN: 36.39 (-0.04)
Medtronic Gains on Positive 2-Year CoreValve Trial Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 20, 1:10PM CDT
Medtronic (MDT) revealed that patients implanted with its CoreValve System shows superior survival benefit compared to those who undergo open heart surgery.
MDT: 78.01 (+0.93), PAHC: 33.44 (+1.09), ABAX: 63.25 (-0.09), LMAT: 8.44 (-0.10)
Medtronic Up on Positive Preclinical Drug-Filled Stent Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 19, 1:00PM CDT
Medtronic plc (MDT) has planned to start a clinical trial ??? a first of its kind ??? involving the study of Medtronic's novel Drug-Filled Stent (DFS) system, over the coming months.
MDT: 78.01 (+0.93), PAHC: 33.44 (+1.09), ABAX: 63.25 (-0.09), LMAT: 8.44 (-0.10)
Boston Scientific's Heart Device Wins FDA Nod, CE Mark - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 19, 12:50PM CDT
Recently, Boston Scientific simultaneously won the U.S. Food and Drug Administration (FDA) approval and the European CE Mark for its Emblem Subcutaneous Implantable Defibrillator (S-ICD) System.
BSX: 18.41 (+0.10), PAHC: 33.44 (+1.09), ABAX: 63.25 (-0.09), LMAT: 8.44 (-0.10)
Baxter's BAX 817 Tests Positive for Hemophilia Treatment - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 17, 3:26PM CDT
Following the release of this positive data on Mar 13, shares of Baxter International Inc. (BAX) climbed 0.6% to close at $67.36 the same day.
PAHC: 33.44 (+1.09), ABAX: 63.25 (-0.09), BAX: 70.38 (+0.33), LMAT: 8.44 (-0.10)
St. Jude Medical Releases Positive CardioMEMS HF Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 17, 2:10PM CDT
St. Jude Medical Inc. (STJ) plans to pioneer an entirely new market with its CardioMEMS technology and expects the same to become a major new growth driver in 2015 and beyond.
PAHC: 33.44 (+1.09), ABAX: 63.25 (-0.09), LMAT: 8.44 (-0.10), STJ: 73.55 (+4.43)
Medtronic Up on Positive CoreValve Evolut R Study Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 17, 12:35PM CDT
An increased number of physicians are gradually accepting Medtronic's (MDT) CoreValve as a suitable alternative for TAVI in high-risk surgery patients.
MDT: 78.01 (+0.93), PAHC: 33.44 (+1.09), ABAX: 63.25 (-0.09), LMAT: 8.44 (-0.10)
Boston Scientific Up on FDA Nod for WATCHMAN Device - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 17, 12:20PM CDT
Boston Scientific's (BSX) WATCHMAN is the leading device in percutaneous left atrial appendage closure globally and has been used in the treatment of more than 10,000 patients worldwide.
BSX: 18.41 (+0.10), PAHC: 33.44 (+1.09), ABAX: 63.25 (-0.09), LMAT: 8.44 (-0.10)
Medtronic Starts US DES Trial for Small Vessel CAD Patients - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 16, 11:40AM CDT
Medtronic's (MDT) Resolute Onyx DES ??? a next-generation coronary stent ??? incorporates the CoreWire Technology, which offers advanced visibility during the stenting procedure.
MDT: 78.01 (+0.93), PAHC: 33.44 (+1.09), ABAX: 63.25 (-0.09), LMAT: 8.44 (-0.10)
Align Technology, Sirona to Jointly Expand in Orthodontics - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 13, 12:30PM CDT
We believe this partnership will enable Align Technology, Inc. (ALGN) to provide faster, safer and more effective care to its patients.
ALGN: 55.94 (-0.21), PAHC: 33.44 (+1.09), ABAX: 63.25 (-0.09), LMAT: 8.44 (-0.10)
Will Mead Johnson (MJN) Gain From International Expansion? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 12, 1:40PM CDT
Despite observing strong sales growth in Asia in 2014, Mead Johnson (MJN) is concerned about the higher dairy costs in that geographical segment which substantially impacted the company's profit margins in the region.
MJN: 98.92 (-1.00), PAHC: 33.44 (+1.09), ABAX: 63.25 (-0.09), LMAT: 8.44 (-0.10)
Healthcare ratings roundup
Seeking Alpha - at Seeking Alpha - Tue Apr 21, 8:42AM CDT
IPXL: 49.58 (-0.40), ROSG: 3.83 (-0.20), BCRX: 10.62 (-0.09), ALGN: 55.94 (-0.21), PAHC: 33.44 (+1.09), BMY: 66.60 (-0.21)
Medtronic, IBM Health Unit Tie Up for Diabetes Management - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 14, 1:40PM CDT
The collaboration with IBM marks yet another milestone for Medtronic (MDT), taking it closer to its aim of transforming diabetes care worldwide.
SRDX: 26.57 (+0.02), MDT: 78.01 (+0.93), PAHC: 33.44 (+1.09), IBM: 165.36 (+1.10), LMAT: 8.44 (-0.10)
NuVasive Poised on Balanced Growth, International Expansion - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 14, 1:30PM CDT
On Apr 13, 2015, we initiated our coverage on NuVasive, Inc. (NUVA).
SRDX: 26.57 (+0.02), PAHC: 33.44 (+1.09), LMAT: 8.44 (-0.10), NUVA: 43.38 (+0.10)
Zimmer (ZMH) Extends Biomet Deal Outside Date to Jul 23 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 14, 1:20PM CDT
Zimmer Holdings Inc. (ZMH) has announced an extension of the "outside date" for completing the proposed Biomet merger.
ZMH: 117.49 (+0.12), SRDX: 26.57 (+0.02), PAHC: 33.44 (+1.09), LMAT: 8.44 (-0.10)
The Growing Business Of Animal Healthcare
Value Line - Seeking Alpha - Tue Apr 14, 7:44AM CDT
By George M. Lee Despite an uneven economic recovery, demand for higher-quality animal healthcare continues to increase. Veterinary spending on pets has grown at a steady clip in recent years and ought to remain strong. Meanwhile many farmers...
VRX: 206.93 (-3.92), PAHC: 33.44 (+1.09), PFE: 34.93 (+0.04), WMT: 78.43 (+0.40), PDCO: 47.34 (+0.13), PETX: 16.15 (+0.01), LLY: 72.30 (+0.09), KIN: 7.45 (+0.25), ZTS: 47.03 (-0.51), ABC: 113.81 (-0.08), MWIV: 190.00 (+0.10), ABAX: 63.25 (-0.09), MRK: 57.69 (+0.03), ICCC: 6.32 (+0.19), TGT: 81.34 (+0.09), IDXX: 155.97 (+0.75), WOOF: 55.13 (-0.18), HSIC: 141.11 (+1.14), NVS: 103.45 (-0.62), PETM: 82.98 (+0.03)
Phibro Animal Health Corporation to Participate in Bank of America Merrill Lynch 2015 Health Care Conference
GlobeNewswire - Mon Apr 06, 12:00PM CDT
Phibro Animal Health Corporation (Nasdaq
AHC) Chairman, President and Chief Executive Officer Jack Bendheim and Chief Financial Officer Richard Johnson will address financial analysts and investors at the Bank of America Merrill Lynch 2015 Health Care Conference. PAHC: 33.44 (+1.09)
Phibro Animal Health Corporation to Host Webcast and Conference Call on March 2015 Quarterly Financial Results
GlobeNewswire - Mon Apr 06, 12:00PM CDT
Phibro Animal Health Corporation (Nasdaq
AHC) will host a webcast and conference call to review third quarter financial results. A news release containing quarterly results is expected to be issued after the market closes on Monday, May 11, 2015. PAHC: 33.44 (+1.09)
NYSE Notice for Hanger for Non Compliance with 10-K Norms - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 24, 3:10PM CDT
Hanger Inc. (HGR) recently received a notice from the New York Stock Exchange (NYSE) stating that the company is not complying with the NYSE's continued listing requirements under the timely filing criteria outlined in Section 802.01E of the NYSE Listed Company Manual.
SRDX: 26.57 (+0.02), PAHC: 33.44 (+1.09), LMAT: 8.44 (-0.10), HGR: 24.27 (+0.36)
Abaxis' (ABAX) Decision to Divest AVRL: A Strategic Fit? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 24, 1:00PM CDT
Abaxis, Inc. (ABAX), recently agreed to sell off its AVRL (Abaxis Veterinary Reference Laboratory) business to renowned animal healthcare company VCA Inc. (WOOF).
PAHC: 33.44 (+1.09), ABAX: 63.25 (-0.09), LMAT: 8.44 (-0.10), WOOF: 55.13 (-0.18)
LeMaitre Vascular a Strong Buy on Impressive Q4 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 23, 5:34PM CDT
On Mar 19, 2015, Zacks Investment Research raised LeMaitre Vascular Inc. (LMAT) to a Zacks Rank #1 (Strong Buy).
PAHC: 33.44 (+1.09), ABAX: 63.25 (-0.09), LMAT: 8.44 (-0.10), INGN: 36.39 (-0.04)
Medtronic Gains on Positive 2-Year CoreValve Trial Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 20, 1:10PM CDT
Medtronic (MDT) revealed that patients implanted with its CoreValve System shows superior survival benefit compared to those who undergo open heart surgery.
MDT: 78.01 (+0.93), PAHC: 33.44 (+1.09), ABAX: 63.25 (-0.09), LMAT: 8.44 (-0.10)
Medtronic Up on Positive Preclinical Drug-Filled Stent Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 19, 1:00PM CDT
Medtronic plc (MDT) has planned to start a clinical trial ??? a first of its kind ??? involving the study of Medtronic's novel Drug-Filled Stent (DFS) system, over the coming months.
MDT: 78.01 (+0.93), PAHC: 33.44 (+1.09), ABAX: 63.25 (-0.09), LMAT: 8.44 (-0.10)
Boston Scientific's Heart Device Wins FDA Nod, CE Mark - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 19, 12:50PM CDT
Recently, Boston Scientific simultaneously won the U.S. Food and Drug Administration (FDA) approval and the European CE Mark for its Emblem Subcutaneous Implantable Defibrillator (S-ICD) System.
BSX: 18.41 (+0.10), PAHC: 33.44 (+1.09), ABAX: 63.25 (-0.09), LMAT: 8.44 (-0.10)
Baxter's BAX 817 Tests Positive for Hemophilia Treatment - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 17, 3:26PM CDT
Following the release of this positive data on Mar 13, shares of Baxter International Inc. (BAX) climbed 0.6% to close at $67.36 the same day.
PAHC: 33.44 (+1.09), ABAX: 63.25 (-0.09), BAX: 70.38 (+0.33), LMAT: 8.44 (-0.10)
St. Jude Medical Releases Positive CardioMEMS HF Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 17, 2:10PM CDT
St. Jude Medical Inc. (STJ) plans to pioneer an entirely new market with its CardioMEMS technology and expects the same to become a major new growth driver in 2015 and beyond.
PAHC: 33.44 (+1.09), ABAX: 63.25 (-0.09), LMAT: 8.44 (-0.10), STJ: 73.55 (+4.43)
Medtronic Up on Positive CoreValve Evolut R Study Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 17, 12:35PM CDT
An increased number of physicians are gradually accepting Medtronic's (MDT) CoreValve as a suitable alternative for TAVI in high-risk surgery patients.
MDT: 78.01 (+0.93), PAHC: 33.44 (+1.09), ABAX: 63.25 (-0.09), LMAT: 8.44 (-0.10)
Boston Scientific Up on FDA Nod for WATCHMAN Device - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 17, 12:20PM CDT
Boston Scientific's (BSX) WATCHMAN is the leading device in percutaneous left atrial appendage closure globally and has been used in the treatment of more than 10,000 patients worldwide.
BSX: 18.41 (+0.10), PAHC: 33.44 (+1.09), ABAX: 63.25 (-0.09), LMAT: 8.44 (-0.10)
Medtronic Starts US DES Trial for Small Vessel CAD Patients - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 16, 11:40AM CDT
Medtronic's (MDT) Resolute Onyx DES ??? a next-generation coronary stent ??? incorporates the CoreWire Technology, which offers advanced visibility during the stenting procedure.
MDT: 78.01 (+0.93), PAHC: 33.44 (+1.09), ABAX: 63.25 (-0.09), LMAT: 8.44 (-0.10)
Align Technology, Sirona to Jointly Expand in Orthodontics - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 13, 12:30PM CDT
We believe this partnership will enable Align Technology, Inc. (ALGN) to provide faster, safer and more effective care to its patients.
ALGN: 55.94 (-0.21), PAHC: 33.44 (+1.09), ABAX: 63.25 (-0.09), LMAT: 8.44 (-0.10)
Will Mead Johnson (MJN) Gain From International Expansion? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 12, 1:40PM CDT
Despite observing strong sales growth in Asia in 2014, Mead Johnson (MJN) is concerned about the higher dairy costs in that geographical segment which substantially impacted the company's profit margins in the region.
MJN: 98.92 (-1.00), PAHC: 33.44 (+1.09), ABAX: 63.25 (-0.09), LMAT: 8.44 (-0.10)
